InfraTrac is a venture-backed start-up company, founded to provide a new way to track and detect counterfeit drugs. Better than RFID and EPC, InfraTrac actually tags and tracks the drug itself, making it impossible for the counterfeiter to escape undetected.

InfraTrac’s principal competition comes from physical tags (RFID and EPC) and special inks. Competition may also come from proprietary techniques under development at affected pharmaceutical companies. However, InfraTrac’s patent protection (priority 2003) is expected to cover those techniques.

InfraTrac applications go beyond pharmaceuticals, to any product that needs tracking and anti-counterfeiting measures. Gasoline, plastics, fabrics, even paint can use InfraTrac’s technology, so you can tell the fakes from the real thing.

Investors

Saffron Hill Ventures is a London-based early-stage venture capital firm. Several of Saffron Hill’s other portfolio companies also link software and health. InfraTrac has received an MTTF award from the Maryland Technology Development Corporation (TEDCO) for developing formulation software.